
Aspire Remedies Private Limited
Pharmaceutical trading company established in 2003 with headquarters in Delhi.
Pharmaceutical trading company established in 2003 with headquarters in Delhi.
Aspire Remedies Private Limited (ARPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 July 2003 and has a history of 21 years and seven months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.20 M and a paid-up capital of Rs 1.20 M.
The company currently has active open charges totaling ₹3.24 M.
Rajinder Khosla, Bahadur Singh, and Sunita Rani serve as directors at the Company.
Delhi, India
+91-XXXXXXXXXX
-
U24231DL2003PTC121261
121261
Private Limited Indian Non-Government Company
10 Jul 2003
30 Sep 2023
31 Mar 2023
Unlisted
Roc Delhi
Aspire Remedies Private Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Blood Pressure Medicine, Digestive System Drugs & Medicines, Antacid Drugs, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Pain Relief Drugs & Pharmaceuticals, Diclofenac, Common Disease Medicines, Antiseptic Mouthwashes.
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rajinder Khosla ![]() | Director | 10-Jul-2003 | Current |
Bahadur Singh ![]() | Director | 05-Aug-2003 | Current |
Sunita Rani ![]() | Additional Director | 22-Feb-2015 | Current |
Aspire Remedies Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.31% increase. The company also saw a slight improvement in profitability, with a 7.46% increase in profit. The company's net worth moved up by a moderate rise of 7.62%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, Aspire Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
₹3.24 M
₹0
Date | Lender | Amount | Status |
---|---|---|---|
20 May 2023 | Canara Bank | ₹0.56 M | Open |
19 Apr 2023 | Canara Bank | ₹1.50 M | Open |
14 Jul 2020 | Others | ₹0.18 M | Open |
08 Feb 2012 | Others | ₹1.00 M | Open |
Aspire Remedies has a workforce of 20 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Aspire Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aspire Remedies's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Aspire Remedies Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
30 Sep 2023
A charge with Canara Bank amounted to Rs. 0.56 M with Charge ID 100719801 was registered on 20 May 2023.
20 May 2023
A charge with Canara Bank amounted to Rs. 1.50 M with Charge ID 100706777 was registered on 19 Apr 2023.
19 Apr 2023
Aspire Remedies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.
31 Mar 2023
A charge with Others amounted to Rs. 0.18 M with Charge ID 100368223 was registered on 14 Jul 2020.
14 Jul 2020
A charge with Others of Rs. 1.00 M registered on 08 Feb 2012 with Charge ID 10341235 was modified on 28 Nov 2017.
28 Nov 2017
Aspire Remedies Private Limited was incorporated on 10 Jul 2003.
The authorized share capital of Aspire Remedies Private Limited is ₹ 1.20 M and paid-up capital is ₹ 1.20 M.
Currently 3 directors are associated with Aspire Remedies Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Aspire Remedies Private Limited is A-5 2Nd Floor Front Side, Mukhram Garden India, New Delhi, 110018.
The corporate identification number (CIN) of Aspire Remedies Private Limited is U24231DL2003PTC121261 and the company number is 121261 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Aspire Remedies Private Limited has risen by 5.31%.
As Per 2023 financial reports, 20 employees are currently employed by Aspire Remedies Private Limited.
The financial reports for the fiscal year 2023 indicates that The net worth of Aspire Remedies Private Limited has experienced an upsurge of 7.62%.
As per the financial statements for fiscal Year 2023, The total open charges for Aspire Remedies Private Limited amount to ₹ 3.24 M.
The most recent Balance Sheet for Aspire Remedies Private Limited was filed with the ROC on 31 Mar 2023.